 2. Biopsy-proven, grade II-IV aGVHD following allogeneic hematopoietic stem cell transplantation HSCT of any source bone marrow, peripheral blood or cord blood stem cells. Enrollment may be started prior to results of biopsy in cases of high clinical suspicion for aGVHD. 